Respirtech, Inc.
RespirTech is dedicated to helping people with chronic respiratory conditions breathe easier through advanced airway clearance devices and comprehensive support services. Since 2004, they have focused on improving quality of life for patients with conditions like cystic fibrosis, bronchiectasis, COPD, and neuromuscular diseases, offering innovative therapies such as the Philips InCourage vest therapy and CoughAssist T70. Their services include clinical support, insurance navigation, and ongoing patient follow-up, with a strong emphasis on research, clinical evidence, and patient registry data to demonstrate the effectiveness of their solutions.
Industries
Nr. of Employees
medium (51-250)
Respirtech, Inc.
Products
Home-use HFCWO vest therapy system (vest + control unit)
A home-use high-frequency chest wall oscillation vest system that delivers chest compression waveforms (including triangular waveform and active venting) to mobilize and clear mucus from the lungs.
Mechanical insufflation–exsufflation (MI-E) cough assist device
A non‑invasive cough assistance device that applies positive followed by negative pressure to aid secretion clearance in patients unable to cough effectively.
Home-use HFCWO vest therapy system (vest + control unit)
A home-use high-frequency chest wall oscillation vest system that delivers chest compression waveforms (including triangular waveform and active venting) to mobilize and clear mucus from the lungs.
Mechanical insufflation–exsufflation (MI-E) cough assist device
A non‑invasive cough assistance device that applies positive followed by negative pressure to aid secretion clearance in patients unable to cough effectively.
Services
Assignment of a patient service advocate, clinical training by licensed respiratory therapists and nurses, in-home setup and education, and proactive follow-up during the first months of therapy.
Preparation and submission of documentation for prior authorization and claims, coordination with prescribers and follow-up on coverage decisions for commercial and government payers.
Longitudinal follow-up calls and data collection for up to two years, generation of patient-specific and aggregate outcome reports to inform clinical care and adherence interventions.
VA-focused intake, eligibility guidance, ordering assistance and a VA outcomes follow-up program tailored to veterans receiving airway clearance therapy.
Coordination of equipment delivery to the patient’s home, scheduling of setup and training visits, and ongoing logistics support between prescribers and patients.
Assignment of a patient service advocate, clinical training by licensed respiratory therapists and nurses, in-home setup and education, and proactive follow-up during the first months of therapy.
Preparation and submission of documentation for prior authorization and claims, coordination with prescribers and follow-up on coverage decisions for commercial and government payers.
Longitudinal follow-up calls and data collection for up to two years, generation of patient-specific and aggregate outcome reports to inform clinical care and adherence interventions.
VA-focused intake, eligibility guidance, ordering assistance and a VA outcomes follow-up program tailored to veterans receiving airway clearance therapy.
Coordination of equipment delivery to the patient’s home, scheduling of setup and training visits, and ongoing logistics support between prescribers and patients.
Expertise Areas
- Airway clearance therapy (HFCWO and MI-E)
- Clinical support, patient education and home training
- Patient registry management and longitudinal outcomes research
- Device data capture and therapy analytics
Key Technologies
- High-frequency chest wall oscillation (HFCWO)
- Triangular waveform modulation for mechanical chest compression
- Active venting for patient comfort/adherence
- Mechanical insufflation–exsufflation (MI-E) devices
News & Updates
RespirTech presented clinical posters at ATS 2019, ATS 2017, and CHEST 2020 conferences on the outcomes of high-frequency chest wall oscillation in bronchiectasis and COPD patients.
A peer-reviewed paper published in Therapeutic Advances in Respiratory Disease, June 2019, discussing the effectiveness of HFCWO in bronchiectasis.
Largest bronchiectasis patient registry
RespirTech holds the world's largest bronchiectasis patient registry, with ongoing follow-up and data collection to improve patient care.
RespirTech presented clinical posters at ATS 2019, ATS 2017, and CHEST 2020 conferences on the outcomes of high-frequency chest wall oscillation in bronchiectasis and COPD patients.
A peer-reviewed paper published in Therapeutic Advances in Respiratory Disease, June 2019, discussing the effectiveness of HFCWO in bronchiectasis.
Largest bronchiectasis patient registry
RespirTech holds the world's largest bronchiectasis patient registry, with ongoing follow-up and data collection to improve patient care.